Are you Dr. Shizuru?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 41 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-497-8000- Is this information wrong?
Summary
- Dr. Judith Shizuru, MD is an oncologist in Stanford, California. She is currently licensed to practice medicine in California. She is affiliated with Stanford Health Care and is an Associate Professor at Stanford University Medical Center.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1994 - 1997
University of California (San Francisco)Residency, Internal Medicine, 1992 - 1994
Stanford University School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2026- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Bone Marrow Grafting for Leukemia and Lymphoma Start of enrollment: 1988 Mar 01
- Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus Start of enrollment: 2004 Jun 01
- Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2007 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsAnti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells.Chiara F Magnani, Renier Myburgh, Silvan Brunn, Morgane Chambovey, Marianna Ponzo, Laura Volta, Francesco Manfredi, Christian Pellegrino, Steve Pascolo, Csaba Miskey, ...> ;Molecular Therapy Oncolytics. 2023 Sep 21
- 7 citationsImproved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents.Rezvani, A. R., Michael A Spinner, R A Sica, John S Tamaresis, Ying Lu, Cheryl Chang, Robert Lowsky, Matthew J Frank, Laura J Johnston, David B Miklos, Lori S Muffly, ...> ;Blood. 2023 Jun 1
- 3 citationsCurative islet and hematopoietic cell transplantation in diabetic mice without toxic bone marrow conditioning.Charles A Chang, Preksha Bhagchandani, Jessica Poyser, Brenda J Velasco, Weichen Zhao, Hye-Sook Kwon, Everett Meyer, Judith A Shizuru, Seung K Kim> ;Cell Reports. 2022 Nov 8
- Join now to see all
Press Mentions
Fred Hutch Hosts Inaugural Dr. E. Donnall Thomas SymposiumOctober 7th, 2022- Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 2nd, 2021
Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting & ExpositionDecember 9th, 2019- Join now to see all
Grant Support
- Overcoming Resistance To Engraftment In Non-Myeloablated RecipientsNational Heart, Lung, And Blood Institute2010–2011
- Transplantation Of Purified Hematopoietic Cell Populations Acroos Allogenic BarieNational Cancer Institute2007–2011
- Isolation And Transplantation Of Candidate Alveolar Progenitor CellsNational Heart, Lung, And Blood Institute2007–2010
- Barriers To Allogeneic Hematopoietic Stem Cell EngraftmentNational Heart, Lung, And Blood Institute2007–2010
- Isolation And Characterization Of Lung Alveolar ProgenitorsNational Heart, Lung, And Blood Institute2007
- Diabetes Allele Transfer By Hematopoietic Cell Transpl.National Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Hematopoietic Cell Transplants For Autoimmune DiseasesNational Institute Of Allergy And Infectious Diseases2001–2005
- Barriers To Allogenic Transplantation Of Purified Hsc'SNational Cancer Institute2002
Hospital Affiliations
Stanford Health CarePalo Alto, California
